Literature DB >> 19590446

Cryoglobulin crystal arthropathy in a patient with multiple myeloma.

Alejandra C Rodriguez-Paez1, Mythili Seetharaman, Lawrence H Brent.   

Abstract

Joint involvement is unusual in patients with monoclonal gammopathies. It has been characteristically described as a rheumatoid-like seronegative polyarticular erosive arthropathy, which also has been related to crystal deposition of cryoglobulins in the synovium and several other tissues. This report describes the case of a 57-year-old African American woman with a seronegative polyarthritis associated with deposition of nonbirefringent or weakly positive birefringent rhomboid-shaped crystals in the synovial fluid. The patient, who was subsequently diagnosed with multiple myeloma, showed good clinical response to oral and intra-articular corticosteroids. Type II cryoglobulins were identified in the serum as well as in the synovial fluid. It is important to consider this association as part of the differential diagnosis of a patient with multiple myeloma and arthritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19590446     DOI: 10.1097/RHU.0b013e3181a567b5

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  3 in total

1.  Intravascular crystal deposition: an early clue to the diagnosis of type 1 cryoglobulinemic vasculitis.

Authors:  Bryan Gammon; Michelle Longmire; Brittney DeClerck
Journal:  Am J Dermatopathol       Date:  2014-09       Impact factor: 1.533

2.  Lenalidomide for the treatment of cryoglobulinemia and undifferentiated spondyloarthropathy in a patient with multiple myeloma.

Authors:  Richard J Lin; James J Curran; Todd M Zimmerman; Jie Song; Timothy B Niewold; Nadera J Sweiss
Journal:  J Clin Rheumatol       Date:  2010-03       Impact factor: 3.517

Review 3.  Intracellular and extracellular rhomboid shaped crystalline inclusions in a case of IgG lambda restricted plasma cell myeloma: a case report and review of the literature.

Authors:  Andres Matoso; Tina Rizack; Diana O Treaba
Journal:  Diagn Pathol       Date:  2010-01-21       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.